Overview
Lisa Guerra is a General Surgeon in Newport Beach, California. Dr. Guerra is rated as an Experienced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Intraductal Papilloma, Angiosarcoma, and Mastectomy.
Her clinical research consists of co-authoring 9 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1441 Avocado Ave, Suite 301, Newport Beach, CA 92660
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
City Of Hope Medical Foundation
Katharine Schulz-Costello is a General Surgeon in Arcadia, California. Dr. Schulz-Costello is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, HER-2 Positive Breast Cancer, and Triple-Negative Breast Cancer.
City Of Hope Medical Foundation
Jennifer Tseng is a Surgical Oncologist and a General Surgeon in Newport Beach, California. Dr. Tseng is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Bone Marrow Aspiration, and Lymphadenectomy. Dr. Tseng is currently accepting new patients.
City Of Hope Medical Foundation
Antoine Carre is a General Surgeon and a Plastic Surgeon in Torrance, California. Dr. Carre is rated as an Advanced provider by MediFind in the treatment of HER2 Negative Breast Cancer. His top areas of expertise are Breast Cancer, Angiosarcoma, Paget Disease of the Breast, Mastectomy, and Lymphadenectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Guerra isDistinguished. Learn about Breast Cancer.
- Intraductal PapillomaDr. Guerra isDistinguished. Learn about Intraductal Papilloma.
- Paget Disease of the BreastDr. Guerra isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- AngiosarcomaDr. Guerra isAdvanced. Learn about Angiosarcoma.
- Breast LumpDr. Guerra isAdvanced. Learn about Breast Lump.
- FibroadenomaDr. Guerra isAdvanced. Learn about Fibroadenoma.
- Giant Mammary HamartomaDr. Guerra isAdvanced. Learn about Giant Mammary Hamartoma.
- Inflammatory Breast CancerDr. Guerra isAdvanced. Learn about Inflammatory Breast Cancer.
- MastectomyDr. Guerra isAdvanced. Learn about Mastectomy.
- Experienced
- BRCA Positive Breast CancerDr. Guerra isExperienced. Learn about BRCA Positive Breast Cancer.
- Breast InfectionDr. Guerra isExperienced. Learn about Breast Infection.
- EscharDr. Guerra isExperienced. Learn about Eschar.
- Fibrocystic Breast DiseaseDr. Guerra isExperienced. Learn about Fibrocystic Breast Disease.
- GalactocoeleDr. Guerra isExperienced. Learn about Galactocoele.
- HER-2 Positive Breast CancerDr. Guerra isExperienced. Learn about HER-2 Positive Breast Cancer.